APPOINTMENTS
Surgical Coordinator BreastScreen SA, commenced September 2001.
COMMITTEES
-
Chairman SNAC Trial Management Committee.
-
Committee For The Introduction Of New Technologies The National Breast
Cancer Centre.
RESEARCH
The principal area of research currently involves Sentinel Node Biopsy
(SNB) in breast cancer, and melanoma. The Breast and Surgical Oncology
Unit at the Royal Adelaide Hospital has developed the technique within
Australasia, and has published data on outcomes, as well as on methodology,
surgical technique and specific variables which influence success of the
technique. We have recently introduced intensive courses in the science
and practice of SNB for Australian surgeons.
The trial comparing Sentinel Node Biopsy with Azillary Clearance in
women with operable breast cancer is well established. As at July 14th,
2002, 664 women had been randomised and 23 centres are participating in
Australia and New Zealand. The Group has received funding from the NH&MRC
for 5 years, and we anticipate the completion of accrual in mid-2004.
We are working closely with Dr G Farshid in Tissue Pathology, on an
optimal method of evaluating the SN status, and with Dr Rudzki?s team in
Molecular Genetics, on comparison of and validation of, the assessment
of the status of the HER-2 oncogene by PCR techniques and immunohistochemical
assessment of antibody expression. (Dr Anoo Raman, Dr G Farshid).
I have contributed to the Australian study of the oncolysate vaccine
in high risk melanoma patients, and currently participate in new studies
involving the use of the C-vax vaccine from UCLA. Previous work in the
department has demonstrated strong associations between melanoma and other
tumours, and these will be revisited and expanded.
The Breast Unit is actively involved in studies of endocrine therapy
in early breast cancer, as well as supporting the ANZ Breast Cancer Trial
Group studies in adjuvant chemotherapy.
PUBLICATIONS
Borg M, Yeoh E, Bochner M, Butters J, van Doorn T, Farshid G, Kollias J, Kotasek D, Gill G, Lim A, Olver I, Parnis F, Rush G. Feasibility study on the Mammosite in early stage breast cancer: Initial experience. Australasian Radiology 2007: 51:53-61.
Farshid G, Downey P, Gill PG. Atypical presentations of screen-detected DCIS implications for pre-operative assessment and surgical intervention. The Breast 2007: 16: 161-171.
Luke C, Gill G, Birrell S, Humeniuk V, Borg M, Karapetis C, Koczwara B, Olver I, Penniment M, Pittman K, Price T, Walsh D, Yeoh E, Roder D. Treatment and survival from breast cancer: the experience of patients at South Australian teaching hospials between 1977 and 2003. Journal of Evaluation in Clinical Practice 2007: 13: 212-220.
Gill PG, Luke CG, Roder DM. Clinical and pathological factors predictive of lymph node status in women with screen-detected breast cancer. T he Breast 2006; 15: 640-648.
GRANTS
National Health & Medical Research Grant $1,204,135.00 for 2003-2007. Sentinel Node Biopsy Versus Axillary Clearance In Operable Breast Cancer (The SNAC Trial). Gill, PG.
AntiCancer Foundation SA $55,000.00 over two year. Sentinel Node Biopsy Versus Axillary Clearance In Operable Breast Cancer (The SNAC Trial) Gill, PG.
The National Breast Cancer Foundation - $303,437.00 over three years. Sentinel Node Biopsy Versus Axillary Clearance In Operable Breast Cancer (The SNAC Trial). Gill, PG.
|
